VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $573,423 | -21.1% | 11,248 | -22.8% | 0.26% | -20.4% |
Q2 2023 | $727,176 | -1.0% | 14,561 | -25.7% | 0.33% | -44.4% |
Q1 2023 | $734,833 | -21.8% | 19,606 | 0.0% | 0.60% | +7.3% |
Q4 2022 | $940,108 | +87.6% | 19,606 | -6.1% | 0.56% | +95.1% |
Q3 2022 | $501,000 | -17.7% | 20,870 | -25.4% | 0.29% | -22.3% |
Q2 2022 | $609,000 | – | 27,965 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |